Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

This post was originally published on MarketWatch

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.